Resonance Health Ltd today announced that its wholly-owned subsidiary Resonance Health Analysis Services (RHAS), has been awarded a Department of Health, Government of Western Australia (WA) Health supply contract.
The contract ensures the supply of the FerriScan technology to all capable public hospital
Magnetic Resonance Imaging (MRI) centres in the State. The first MRI centre to offer FerriScan as part of the contract is located at Fremantle Hospital.
Patients will now be able to access FerriScan through the WA public hospital system with no
direct cost to the patient. Costs associated with the provision of the FerriScan service are
reimbursed in full under the contract, with RHAS receiving its standard commercial fee for the
provision of the FerriScan service.
"We anticipate that this supply contract in WA will provide a foundation to expand the provision
of a reimbursed FerriScan service into other States, allowing greater access to FerriScan and
improved health outcomes for people at risk from the debilitating effects of iron overload," said
Dr James Williams, Managing Director of Resonance Health.
RHAS was awarded the supply contract after an exemption from tender was granted on the
basis that RHAS was the sole supplier of a regulatory cleared MRI method for non-invasive
measurement of Liver Iron Concentration (LIC).
Approximately 1 in every 200 Australians have the genetic defect, which causes the iron
overload condition "Hereditary Haemochromatosis". It is estimated that 1000 West Australians
are currently under clinical management for their iron overload conditions with thousands more
at risk and requiring evaluation. |
Login
